ÂÜÀòÂÒÂ×

His entrepreneurial career started in 1982, founding a number of companies in Public Relations, Technology, Advertising, and Music & Personality management backed by The Abingdon Management Company Limited, where he subsequently became sole owner having acquired Abingdon from its institutional shareholders. Abingdon had a number of quoted and unquoted investments including a Unit Trust, Foretronic (a technology company that introduced the magnetic data strip on the back of credit cards), TVS (ITV franchise for the South of England), and a significant property portfolio in the UK and abroad.

Returning to his medical roots, Geoffrey developed and guided Oncimmune, a company pioneering technologies to enable early cancer detection, from a Nottingham University start-up through to a successful IPO in May 2016, with total funds raised of £62m. During this period he co-authored numerous scientific and health economic publications.

He now acts as an advisor to leading technology and healthcare funds, advising investment teams, and specific due diligence projects, monitoring investments as a director, and mentoring CEOs.